Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_2
2
67%
Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Other(3)

Detailed Status

unknown3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 22 (66.7%)
N/A1 (33.3%)

Trials by Status

unknown3100%

Recent Activity

0 active trials
Showing 3 of 3
unknownphase_2

A 12-weeks Study to Evaluate Sulforaphane in the Treatment of Depression

NCT04246905
unknownphase_2

Effects of Sulforaphane on Cognitive Function in Patients With Frontal Brain Damage

NCT04252261
unknownnot_applicable

Investigation of Supplemental L-alanine in the Management of Dietary Fructose Intolerance

NCT04022434

Clinical Trials (3)

Showing 3 of 3 trials
NCT04246905Phase 2

A 12-weeks Study to Evaluate Sulforaphane in the Treatment of Depression

Unknown
NCT04252261Phase 2

Effects of Sulforaphane on Cognitive Function in Patients With Frontal Brain Damage

Unknown
NCT04022434Not Applicable

Investigation of Supplemental L-alanine in the Management of Dietary Fructose Intolerance

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3